Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Metro advertisements for Doctors Without Borders, photos by Drew Angerer Photograph by Drew Angerer / MSF
Press release
Press release |
15 November 2017
Intellectual property and trade

MSF welcomes the suspension of harmful intellectual property measures in new TPP trade deal

Celumusa Hlatswako, an MSF mobile counsellor, visits Winile, an XDR-TB patient, at home in Manzini Region, Swaziland. Photograph by Alexis Huguet
Press release
Press release |
15 November 2017
Tuberculosis

MSF and Stop TB Partnership give governments deadline to dramatically increase access to testing and treatment

what-does-the-msf-access-campaign-do Photograph by Todd Brown
Press release
Press release |
31 October 2017
Hepatitis C

MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag

Photograph by Daro Sulakauri Photograph by Daro Sulakauri
Press release
Press release |
30 October 2017
Tuberculosis

Médecins Sans Frontières response to the World Health Organization Global Tuberculosis Report

Patent Law in South Africa MSF
Press release
Press release |
24 October 2017
Intellectual property and trade
South Africa

Patient groups march for access to medicines in South Africa

6 min
Photograph by Sandra Smiley Photograph by Sandra Smiley
Press release
Press release |
20 October 2017
Intellectual property and trade
JapanASEAN

RCEP negotiations should not restrict global access to affordable medicines and vaccines

Mothers with young children wait for consultation at the MåSF mobile clinic in Pusuguppa, which is a small village in AP along with border of Chhattisgarh. MSF mobile clinic provides free primary health care services which include diagnostic tests, vaccination, malaria and tuberculosis treatment, antenatal and postnatal consultations. Photograph by Sami Siva Photograph by Sami Siva
Press release
Press release |
13 October 2017
Vaccines
India

MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine

Malawi. June 30, 2017. Patrick Chipungu, 51 years, an MSF clinician looks at Simbazako Thove's X-Ray. Simbazako is 19 years and HIV and TB positive. Photograph by Luca Sola
Press release
Press release |
13 October 2017
Tuberculosis

People still being denied improved treatment for multidrug-resistant TB

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury